Concepedia

Mythili Koneru

MK

Statistics

Publications

19

Citations

2.2K

H-Index

16

Active since

2001

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Eli Lilly (United States)

Johnson & Johnson (United States)

New York University

Medical College of Wisconsin

Mythili Koneru is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, cancer immunotherapy, and cancer immunology.

Publications per year

2001–2026

19

Publications

19

IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors <i>in vivo</i>

Mythili Koneru, Terence J. Purdon, David R. Spriggs et al. · OncoImmunology · 2015 · 414 citations · Full text

Life Sciences, Immunology, Oncology +17

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment

Oladapo Yeku, Terence J. Purdon, Mythili Koneru et al. · Scientific Reports · 2017 · 403 citations · Full text

Medicine, Immunology, Oncology +17

A phase I clinical trial of adoptive T cell therapy using IL-12 secreting MUC-16ecto directed chimeric antigen receptors for recurrent ovarian cancer

Mythili Koneru, Roisin E. O’Cearbhaill, Swati Pendharkar et al. · Journal of Translational Medicine · 2015 · 314 citations · Full text

Life Sciences, Immunology, Oncology +17

Differential Gene Expression Associated with Migration of Mesenchymal Stem Cells to Conditioned Medium from Tumor Cells or Bone Marrow Cells

Lata G. Menon, Sonia C. Picinich, Rajeth Koneru et al. · Stem Cells · 2006 · 236 citations · Full text

Life Sciences, Cell Biology, Oncology +14

CD8+ Tumor-Infiltrating T Cells Are Deficient in Perforin-Mediated Cytolytic Activity Due to Defective Microtubule-Organizing Center Mobilization and Lytic Granule Exocytosis

Saša Radoja, Masanao Saio, David Schaer et al. · The Journal of Immunology · 2001 · 157 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 19